Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
About Us
Business Development
Newron seeks to build its portfolio of drug candidates by both in-house research as well as licensing-in and acquiring compounds focused on CNS disorders including pain, at various stages of development. If you would like to contact us in this regard, please send an e-mail to bd@newron.com and we will contact you.